MedPath

Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion

Completed
Conditions
Breast Cancer Female
Diagnoses Disease
Registration Number
NCT03080623
Lead Sponsor
Peking University
Brief Summary

This study proposed to construct an ultrasound-based diagnostic model for Differentiating Malignant Breast Lesion From Benign Lesion. This study contains both retrospective and prospective part, which are designed for model construction and independent validation, respectively.This study aims to construct an easy-to-use ultrasound-based model, prove the efficacy of the model for identifying malignant breast lesion from benign lesion, and finally promote the application of this diagnostic model in more clinics.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1981
Inclusion Criteria
  • female
  • with single breast lesion(maximum diameter>0.8 cm)
  • agree to receive follow-up in six months and take the second breast ultrasound six month after the first breast ultrasound, if a benign diagnosis is achieved at the first ultrasound
  • sign the informed consent
Exclusion Criteria
  • lost to follow-up
  • failed to take the second breast ultrasound six month after the first breast ultrasound

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
breast biopsy proved malignant or benign lesionbetween breast ultrasound and biopsy(one week)

for patients regarded as malignant by the breast ultrasound, breast biopsy results are used as reference test, which determines the breast lesion is malignant or benign

two breast ultrasound identified benign lesionbetween first detection of breast lesion and the second ultrasound(six month)

for patients regarded as benign by the breast ultrasound, they will receive a second breast ultrasound after six month(this is regular examination for patients with first detected breast lesion). If the second ultrasound indicates benign, the lesion will be regarded as benign

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Fourth Hospital of Heibei Medical Hospital

🇨🇳

Shijiazhuang, China

Shunyi women and children's hospital of Beijing Children's Hospital

🇨🇳

Beijing, China

Haidian women and children's hospital of beijing

🇨🇳

Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath